Prognostic Value of CD44 Splice Variants in Human Stage III Cervical Cancer

By Kainz C.   Kohlberger P.   Tempfer C.   Sliutz G.   Gitsch G.   Reinthaller A.   Breitenecker G.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1706-1709

Elsevier

Access to resources Recommend Favorite

CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

By                    

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1570-1578

Spandidos Publications

Access to resources Recommend Favorite

Splice Variants of the Cell Surface Glycoprotein CD44 Associated with Metastatic Tumour Cells are Expressed in Normal Tissues of Humans and Cynomolgus Monkeys

By Heider K.-H.   Mulder J.-W.R.   Ostermann E.   Susani S.   Patzelt E.   Pals S.T.   Adolf G.R.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2385-2391

Elsevier

Access to resources Recommend Favorite

Overexpression of CD44 Variants 6 and 7 in Human Endometrial Cancer

By Katsura M.   Furumoto H.   Nishimura M.   Kamada M.   Aono T.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis

By Lackner C.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 29-40

Springer Publishing Company

Access to resources Recommend Favorite